[Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
D000230:Adenocarcinoma / Q000097:blood*; D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000097:blood*; D005260:Female; D005643:Fucose / Q000097:blood*; D005833:Genital Neoplasms, Female / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood; D011379:Prognosis; D012075:Remission, Spontaneous; D012794:Sialic Acids / Q000097:blood*; D013724:Teratoma / Q000097:blood*; D002583:Uterine Cervical Neoplasms / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood; D014846:Vulvar Neoplasms / Q000097:blood; D000509:alpha-Fetoproteins / Q000032:analysis*
D002272:Carcinoembryonic Antigen; D012794:Sialic Acids; D000509:alpha-Fetoproteins; D005643:Fucose
Próba monitorowania przebiegu choroby u kobiet z nowotworami złośliwymi narzadów płciowych przy pomocy oznaczania poziomów: fukozy, kwasu sjalowego, CEA i AFP w surowicy krwi.